CYP3A4 and neoplasm: The gene expression analysis also revealed that the WT1-positive tumours exhibit poorer response to taxane treatment, which may be linked to their increased levels of CYP3A4, an oxidising enzyme which transforms docetaxel into inactive hydroxylated derivatives65.